Literature DB >> 21439948

The orexin₁ receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats.

Bianca Jupp1, Bedrija Krivdic, Elena Krstew, Andrew J Lawrence.   

Abstract

A role for orexin A in mediating the primary and conditioned reinforcing effects of alcohol has been established. It is unclear however whether the contribution of orexins to alcohol reward occurs independently of effects on appetite and feeding, and whether orexins regulate the motivation to consume alcohol compared to other rewards. To examine this further here we investigate the effect of the orexin(1) receptor antagonist, SB-334867, on self-administration of alcohol (10% v/v) under both fixed (FR) and progressive ratio (PR) schedules of reinforcement, and whether this differs from the motivation to administer a natural food reward, sucrose (0.2-0.7% w/v) in alcohol preferring (iP) rats. SB-334867 treatment significantly reduced responding for both alcohol and sucrose under a FR3 schedule; however, at the same dose, reduced responding and break point for ethanol, but not sucrose, under a PR schedule. These findings for the first time implicate a role for orexins in the motivation to self-administer alcohol and suggest that this may occur independent of any generalized effect on appetitive drive.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439948     DOI: 10.1016/j.brainres.2011.03.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  64 in total

Review 1.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

Review 2.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

3.  Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Brain Res       Date:  2016-10-19       Impact factor: 3.252

Review 4.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

5.  Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2016-02-16       Impact factor: 3.386

Review 6.  The hypothalamus and the neurobiology of drug seeking.

Authors:  Nathan J Marchant; E Zayra Millan; Gavan P McNally
Journal:  Cell Mol Life Sci       Date:  2011-09-23       Impact factor: 9.261

7.  Specific impairments in instrumental learning following chronic intermittent toluene inhalation in adolescent rats.

Authors:  Alec L W Dick; Martin Axelsson; Andrew J Lawrence; Jhodie R Duncan
Journal:  Psychopharmacology (Berl)       Date:  2013-12-10       Impact factor: 4.530

8.  The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.

Authors:  Jirawoot Srisontiyakul; Hanna E Kastman; Elena V Krstew; Piyarat Govitrapong; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2016-08-29       Impact factor: 3.996

9.  Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice.

Authors:  Kelly Lei; Scott A Wegner; Ji-Hwan Yu; F Woodward Hopf
Journal:  Neuropharmacology       Date:  2016-08-11       Impact factor: 5.250

10.  Relaxin-3/RXFP3 system regulates alcohol-seeking.

Authors:  Philip J Ryan; Hanna E Kastman; Elena V Krstew; K Johan Rosengren; Mohammed Akhter Hossain; Leonid Churilov; John D Wade; Andrew L Gundlach; Andrew J Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.